1. Curcumin reverses doxorubicin resistance in colon cancer cells at the metabolic level.
- Author
-
Zhang, Nan, Gao, Ming, Wang, Zihan, Zhang, Jingxian, Cui, Weiqi, Li, Jinjin, Zhu, Xiaolin, Zhang, Hang, Yang, Dong-Hua, and Xu, Xia
- Subjects
- *
POLYAMINES , *GLUTAMINE , *COLON cancer , *CANCER cells , *CURCUMIN , *DOXORUBICIN , *ORNITHINE decarboxylase - Abstract
[Display omitted] • Cur increased the cytotoxicity of Dox in SW620/Ad300 cells. • UPLC/MS-MS based metabolomic was used to explore underlying MDR reversal mechanism. • Up-regulation of polyamine biosynthesis and D-glutamine metabolism were related with MDR. • Cur reduced the biosynthesis of polyamine and D-glutamine metabolism to reverse MDR. • Cur inhibited the ODC expression, thererby decreasing the biosynthesis of polyamine. Doxorubicin (Dox) is commonly used for the treatment of malignant tumors, including colon cancer. However, the development of P-glycoprotein (P-gp)-mediated multidrug resistance (MDR) in tumor chemotherapy has seriously reduced the therapeutic efficacy of Dox. Natural product curcumin (Cur) was demonstrated to have a variety of pharmacological effects, such as anti-tumor, anti-oxidation and anti-aging activities. Here, we examined the MDR reversal capability of Cur in drug sensitive-(SW620) and resistant-(SW620/Ad300) colon cancer cells, and elucidated the underlying molecular mechanisms at the metabolic level. It was found that Cur reversed P-gp-mediated resistance in SW620/Ad300 cells by enhancing the Dox-induced cytotoxicity and apoptosis. Further mechanistic studies indicated that Cur inhibited the ATP-dependent transport activity of P-gp, thereby increasing the intra-celluar accumulation of Dox in drug-resistant cells. Metabolomics analysis based on UPLC-MS/MS showed that the MDR phenomenon in SW620/Ad300 cells was closely correlated with the upregulation of spermine and spermidine synthesis and D-glutamine metabolism. Cur significantly inhibited the biosynthesis of spermine and spermidine by decreasing the expression of ornithine decarboxylase (ODC) and suppressed D-glutamine metabolism, which in turn decreased the anti-oxidative stress ability and P-gp transport activity of SW620/Ad300 cells, eventually reversed MDR. These findings indicated the MDR reversal activity and the related mechanism of action of Cur, suggesting that Cur could be a promising MDR reversal agent for cancer treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF